Dr Rayyan Zafar is a Neuropsychopharmacologist and postdoctoral fellow at Imperial college London researching the clinical and brain effects of psychedelics in addiction. In addition he is the a senior researcher at Drug Science and Chair of Psychedelic Industry UK

Psychedelics Industry UK: The UKs first and only Psychedelics trade association

The psychedelic industry is expanding at a rapid pace as psychedelics become increasingly recognised as viable therapeutic alternatives for mental and physical conditions.  Psychedelic Industry UK (PsyIndUK) is the first and only membership organisation representing the UK’s psychedelics industry. In this talk we will introduce the organisation and its aims and objectives, The trade association will encourage cross-industry knowledge sharing and collaboration, as well as representing the sector with policymakers and regulators. PsyIndUK is led by a team with significant experience and expertise in running organisations, undertaking psychedelic scientific and medical research and policy outputs and raising capital in the biotechnology, medical and wellness spaces. PsyIndUK will address the UK's unique challenges: